RopesTalk

What impact could the pending Supreme Court argument and decision in TC Heartland v. Kraft have on patent infringement litigation in the United States? With the oral argument scheduled for March 27, Doug Hallward-Driemeier, who leads Ropes & Gray’s Supreme Court and Appellate practice, along with Matt Rizzolo and Sam Brenner from the firm’s Intellectual Property Litigation practice offer their perspectives on the case and what it may mean for venue reform in intellectual property litigation.

In this podcast, Doug Hallward-Driemeier, chair of Ropes & Gray’s appellate and Supreme Court practice, moderates a discussion with life sciences partners Kellie Combs and Greg Levine about three key documents recently issued by the FDA related to manufacturer communications.

What impact could the new Trump administration have on the federal judiciary, including the Supreme Court? Having previously served with the Office of the Solicitor General and as Special Assistant and Associate Counsel to President Obama, respectively, Doug Hallward-Driemeier and Justin Florence from Ropes & Gray’s business and securities litigation practice offer their perspectives on what might lie ahead under the new administration.

What impact will the incoming Trump administration have on potential levers of policy change that are available to the Congress and the Executive branch? Having previously served with the Office of the Solicitor General and as Special Assistant and Associate Counsel to President Obama, respectively, Doug Hallward-Driemeier and Justin Florence from Ropes & Gray’s business and securities litigation practice offer their perspectives on what might lie ahead under the new administration.

What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

What impact will the incoming Trump administration have on health care enforcement and False Claims Act cases? In this podcast, Colleen Conry and Alex Rene, partners in Ropes & Gray’s government enforcement practice in Washington, D.C., offer their perspectives on what might lie ahead under a new administration.

Today we will discuss the recently enacted 21st Century Cures law. This is part of the Capital Insights podcasts series we are hosting to examine the issues and potential regulatory changes emanating from Washington, D.C., as we transition to a new Federal administration.

In this podcast, Doug Hallward-Driemeier, chair of Ropes & Gray’s appellate and Supreme Court practice, moderates a discussion with partner Kellie Combs and senior counsel Alan Bennett about the FDA’s open hearings regarding off-label communications.

Ropes & Gray life science partners Gregory Levine (Washington, D.C.), Albert Cacozza (Washington, D.C.) and Michael Beauvais (Boston) cover the latest changes in digital health regulation, investment and transactions, providing insights on disruptive forces, the current and future regulatory landscape, and current and expected investments in the market.